<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Symptom Advice .com &#187; janssen cilag</title>
	<atom:link href="http://symptomadvice.com/tag/janssen-cilag/feed/" rel="self" type="application/rss+xml" />
	<link>http://symptomadvice.com</link>
	<description></description>
	<lastBuildDate>Tue, 29 May 2012 22:17:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Janssen-Cilag receives EU approval for new Invega indication</title>
		<link>http://symptomadvice.com/janssen-cilag-receives-eu-approval-for-new-invega-indication/</link>
		<comments>http://symptomadvice.com/janssen-cilag-receives-eu-approval-for-new-invega-indication/#comments</comments>
		<pubDate>Sat, 08 Jan 2011 23:34:09 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[hepatitis symptoms]]></category>
		<category><![CDATA[janssen cilag]]></category>
		<category><![CDATA[medicines agency]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/janssen-cilag-receives-eu-approval-for-new-invega-indication/</guid>
		<description><![CDATA[Posted on 05/01/2011 &#105;&#110; Pharmaceutical Company Product News Janssen-Cilag has been granted approval &#102;&#114;&#111;&#109; European regulators to market &#105;&#116;&#115; drug Invega as &#097; therapy &#102;&#111;&#114; psychotic &#111;&#114; manic symptoms &#111;&#102; schizoaffective disorder.&#116;&#104;&#101; European Commission approval &#102;&#111;&#108;&#108;&#111;&#119;&#115; &#097; positive recommendation &#102;&#114;&#111;&#109; &#116;&#104;&#101; European Medicines Agency&#039;s Committee &#102;&#111;&#114; Medicinal Products &#102;&#111;&#114; Human Use (CHMP) &#097;&#110;&#100; &#105;&#115; based [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2011/01/1294529649-87.jpg" style="clear:both;clear:both;margin:0 15px 15px 0;width:500px" />
<p><strong>Posted on 05/01/2011 &#105;&#110; Pharmaceutical Company Product News </strong></p>
<p>Janssen-Cilag has been granted approval &#102;&#114;&#111;&#109; European regulators to market &#105;&#116;&#115; drug Invega as &#097; therapy &#102;&#111;&#114; psychotic &#111;&#114; manic symptoms &#111;&#102; schizoaffective disorder.&#116;&#104;&#101; European Commission approval &#102;&#111;&#108;&#108;&#111;&#119;&#115; &#097; positive recommendation &#102;&#114;&#111;&#109; &#116;&#104;&#101; European Medicines Agency&#039;s Committee &#102;&#111;&#114; Medicinal Products &#102;&#111;&#114; Human Use (CHMP) &#097;&#110;&#100; &#105;&#115; based on positive data &#102;&#114;&#111;&#109; recent clinical trials.&#116;&#104;&#105;&#115; makes Invega &#116;&#104;&#101; first &#097;&#110;&#100; only antipsychotic treatment &#102;&#111;&#114; schizoaffective disorder approved &#105;&#110; Europe, with &#116;&#104;&#101; CHMP deeming &#116;&#104;&#097;&#116; &#105;&#116; offers significant clinical benefits compared to current therapy options.Invega has been approved as &#097; schizophrenia treatment since 2007 &#097;&#110;&#100; has been proven to deliver better personal &#097;&#110;&#100; social performance &#102;&#111;&#114; patients.Dr Christophe Tessier, medical affairs director &#102;&#111;&#114; psychiatry at Janssen-Cilag, said: &quot;Janssen &#105;&#115; committed to helping improve &#116;&#104;&#101; lives &#111;&#102; people with &#115;&#101;&#114;&#105;&#111;&#117;&#115; mental illness &#097;&#110;&#100; has &#097; long history &#111;&#102; developing innovative medicines &#105;&#110; &#116;&#104;&#105;&#115; field.&quot;&#116;&#104;&#105;&#115; comes after &#116;&#104;&#101; company announced last month &#116;&#104;&#097;&#116; &#105;&#116; has submitted an application &#102;&#111;&#114; European approval &#111;&#102; telaprevir, &#097; &#110;&#101;&#119; treatment &#102;&#111;&#114; hepatitis C.
<p><strong>Other news &#115;&#116;&#111;&#114;&#105;&#101;&#115; &#102;&#114;&#111;&#109; 05/01/2011</strong></p>
<p><strong>Read &#109;&#111;&#114;&#101; &#105;&#110; &#116;&#104;&#101; Zenopa News Archive</strong></p>
<p><strong>How &#116;&#104;&#105;&#115; news &#105;&#115; generated</strong></p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/janssen-cilag-receives-eu-approval-for-new-invega-indication/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
